AXT Insiders Sold $43M Ahead of AI-Fueled Rally

NEW YORK, May 23 —

AXT, Inc. shares climbed 15.7% in a single session as investors bid up compound semiconductor substrate makers on AI infrastructure demand, pushing the stock to $140.83 and the company's market capitalization to roughly $9.21 billion. The analyst consensus price target is $87.75. The company's own CEO and CFO sold a combined $31.6 million in open-market stock in early March at prices ranging from $36 to $51 a share.

The March Exit

The Form 4 filings tell a specific story. On March 2, 2026, CFO Gary L. Fischer sold 405,233 shares at $41.45, collecting approximately $16.8 million in a single transaction. That same day, CEO Morris S. Young sold 159,536 shares at $43.32, taking home about $6.9 million. Over the following eleven days, Young executed three additional open-market sales: 125,893 shares at $36.51 on March 9 (approximately $4.6 million), 30,832 shares at $45.60 on March 10 (approximately $1.4 million), and 37,905 shares at $51.13 on March 13 (approximately $1.9 million), bringing the CEO's 90-day total to roughly $14.8 million in proceeds.

Directors Jesse Chen and David C. Chang sold through the same window, bringing aggregate insider open-market disposals to $43.27 million across the period. Not one insider filed a Form 4 reflecting an open-market purchase.

The stock now trades at $140.83. Every one of those insider transactions cleared below $52.

A Multiple That Requires a Story

AXT's trailing-twelve-month revenue is approximately $100 million, up 39.1% year-over-year — a strong number for a substrate company with customers building AI infrastructure. Gross margin sits at 21.3%, thin but not unusual for a materials business.

The earnings picture complicates things. Over the three most recently reported quarters, AXT posted per-share losses of $0.15 (versus the consensus estimate of -$0.13), $0.03 (versus -$0.12), and $0.05 (versus -$0.06). The most recent quarter missed estimates. The prior two beat, but on a loss-narrowing basis; the company has not reached profitability. A 187.3x forward P/E on a company still generating losses requires a very specific view of the future to hold together. At $9.21 billion in market cap against $100 million in trailing revenue, the stock reflects a company AXT has not yet become. GuruFocus assigned a GF Score of 58 out of 100 and flagged the stock as overvalued even before the 15.7% single-session move.

Raising Capital Into the Window

Against that backdrop, AXT moved in April. The company filed an S-3ASR automatic shelf registration on April 20, 2026, followed by a 424B5 prospectus supplement on April 20 and another on April 21. On April 21, AXT also filed an 8-K disclosing a Material Definitive Agreement under Item 1.01, consistent with the execution of an underwriting or placement agreement per the filing.

Registered equity offerings via 424B5 filings are standard corporate finance. But the timing matters. The shelf registration and prospectus supplements arrived after the stock had already risen sharply on AI infrastructure optimism, suggesting management moved to capture elevated prices. A company trading at 187x forward earnings can issue equity at a very low dilutive cost. Insiders had already pocketed $43 million in open-market proceeds at prices the stock has since left far behind.

What Changes the Thesis

The bearish case here does not require AXT to be a failing company. Compound semiconductor substrates are real materials going into real applications in photonics and power management, and 39% revenue growth is a real number. If AXT reaches consistent profitability and proves that $100 million in revenue is a floor rather than a ceiling, the valuation math becomes less implausible.

What would need to change: a profitable quarter, gross margin expansion well above 21%, and a reversal of the insider transaction pattern toward purchases rather than sales. None of those conditions are currently in evidence. The analyst consensus target of $87.75 implies roughly 38% downside from current levels. The people who run the company sold $43.27 million in open-market shares at $36 to $51 in early March, then filed to raise additional equity capital in April at elevated prices. That sequence is not a vote of confidence in the current valuation.

Run the free AXT, Inc. deep-dive for a full breakdown of the fundamentals, valuation, and insider transaction history.

Basis Report does not hold positions in securities discussed. This is not investment advice.

Frequently Asked Questions

Why did AXT stock rise 15.7%?

AXT shares gained 15.7% in a single session as investors bid up compound semiconductor substrate makers on AI infrastructure demand. The company reports trailing-twelve-month revenue of approximately $100 million, up 39.1% year-over-year. The rally pushed shares 60% above the analyst consensus price target of $87.75.

Are AXT insiders buying or selling AXTI shares?

Insider activity over the 90-day period covered by recent Form 4 filings shows $43.27 million in aggregate open-market sales and zero purchases. CFO Gary L. Fischer sold approximately $16.8 million in a single transaction on March 2 at $41.45 per share, while CEO Morris S. Young sold approximately $14.8 million across four transactions from March 2 to March 13 at prices ranging from $36.51 to $51.13.

What is AXT's forward P/E ratio?

At $140.83 per share, AXT trades at 187.3 times forward earnings against a market capitalization of approximately $9.21 billion. The company posted per-share losses in each of its three most recently reported quarters, with the most recent quarter coming in at -$0.15, missing the -$0.134 analyst estimate.

What is the analyst price target for AXT stock?

The analyst consensus price target for AXT is $87.75, roughly 38% below the current trading price of $140.83. GuruFocus assigned a GF Score of 58 out of 100 and flagged the stock as overvalued before the 15.7% single-session gain pushed shares further from that benchmark.

Did AXT Inc issue new shares recently?

AXT filed an S-3ASR automatic shelf registration on April 20, 2026, followed by 424B5 prospectus supplements on April 20 and April 21, and an 8-K disclosing a Material Definitive Agreement on April 21, per SEC filings. The filings point to a registered equity offering executed approximately six weeks after the March insider selling window closed.